Stock Market & Financial News
Bloom Energy Spikes 8% as Risk-On Tape Lifts High-Beta Names, FuelCell Ticks Up, Plug Power Stays Flat
A risk-on tape is lifting high-beta fuel cell names on Thursday, but the group is splitting sharply on the way up. Bloom Energy (NYSE:BE) stock is up 8% to $233.69 in midday trading.
BE +4.17% PFG Acquires Beam Benefits to Accelerate Specialty Benefits Growth
Principal Financial's Beam Benefits acquisition expands its SMB reach, adding digital capabilities and supporting stronger Specialty Benefits growth.
PFG -0.25% Mission Produce Q3 Earnings Coming Up: Here's What Lies Ahead
AVO's Q3 outlook faces pressure from lower avocado prices, sourcing costs and blueberry headwinds, though integration and demand offer support.
AVO -0.08% AMAT Rides on AI-Led WFE Demand: Can it Sustain the Momentum?
Applied Materials is benefiting from AI-driven semiconductor demand, with advanced packaging, DRAM and HBM fueling growth as fab investments accelerate globally.
AMAT +2.03% 
COAL Surges 23% in August Driven by Global Power Demand
The Range Global Coal Index ETF (COAL) climbed 23.4% in August, outpacing both broad market equities and energy sector peers. During the month, the State Street SPDR S&P 500 ETF Trust (SPY) climbed 2.7%, while the State Street Energy Select Sector SPDR ETF (XLE) gained 7.4% over the same period.
COAL +0.99% 
Bitcoin price targets $83,450 after falling wedge breakout
Bitcoin price extended its recovery above $80,000 on Sept. 3 after Federal Reserve Governor Christopher Waller cooled expectations for a September rate hike, while the charts showed strong momentum approaching a critical resistance zone.
Uber Partners Wayve as Autonomous Rides Make U.K. Debut: What's Ahead?
Uber and Wayve launch supervised autonomous rides in London, starting a gradual U.K. rollout tied to demand, tech readiness and regulation.
UBER +0.34% 
Will Barclays' Expansion Initiatives Accelerate Top-Line Growth?
BCS' U.S. consumer, U.K. lending, and Investment Banking expansions lift total income by 11% in H1'26, boosting its revenue growth outlook for 2026 & beyond.
BCS +0.3% 
Pfizer's Pipeline Strategy Centers on Obesity and Oncology
PFE's pipeline is taking center stage as berobenatide and next-generation oncology drugs aim to drive growth from 2028 and beyond.
PFE -1.14% 
Campbell's Q4 Earnings Miss Estimates as Inflation Pressures Margins
CPB's Q4 earnings and sales miss estimates as inflation squeezes margins, while Snacks' weakness offsets gains in Meals & Beverages.
CPB +0.67% 
Can The Trade Desk's JBPs Become Its Next Major Growth Engine?
TTD's fast-growing JBPs are emerging as a key growth lever as macro pressures weigh on near-term performance.
TTD -1.24% 
Bitcoin Blasts Past $81,000 as Trump Weighs Ending Iran War
Bitcoin (BTC) reclaimed $81,000 on Thursday as reports suggest the Iran war could be over. Reportedly, Donald Trump's inner circle is advising the president to declare the war officially over, as pressure over midterm elections grows.
Expeditors International of Washington, Inc. (EXPD) Discusses Impact of AI Investment Boom on Freight Markets and Global Supply Chains Transcript
Expeditors International of Washington, Inc. (EXPD) Discusses Impact of AI Investment Boom on Freight Markets and Global Supply Chains Transcript
EXPD +2.52% 
Dogecoin price holds $0.09, but futures activity is losing steam
There isn't enough participation, and the market is in limbo.
Tyson Foods Revises 2026 Outlook Due to ‘Beef Pressures,' And Stock Takes a Hit
Tyson Foods updated its fiscal 2026 outlook Thursday. Investors aren't too pleased.
TSN +2.81% 
Here's Why You Should Add RNTX Stock to Your Portfolio Now
Rein Therapeutics advances LTI-03 in IPF. RENEW enrollment tops 25%, with interim data expected in the fourth quarter of 2026.
RNTX -5.99% 
The Case for Holding MetLife Stock: What Investors Need to Know
MET's diversified portfolio, strong cash generation and global growth support premium gains, while investment income volatility remains a key risk.
MET +0.08% 
ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
AbbVie's Skyrizi, Rinvoq and neuroscience drugs drive growth, but Humira erosion, oncology and Aesthetics remain key headwinds.
ABBV +1.11% 
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. FTNT, EAT, LECO & LRCX are some such stocks.
EAT +3.95% 
One of Trump's Favorite Stocks Just Reported Blowout Earnings
On multiple occasions this year, President Donald Trump has publicly shown his support for Dell Technologies NYSE: DELL, telling Americans to “go out and buy a Dell computer” as recently as July 6.
DELL +3.84% 
Uphold Confirms Earn On XRP In Final Development For 1.62B Tokens
Uphold says its Earn on XRP feature is in final development, targeting a platform that currently holds around 1.62 billion XRP. Because XRPL lacks native staking, Uphold must use external mechanisms such as DeFi lending or wrapped-token infrastructure to generate potential yield.
Equity Bancshares Buys Lincoln Bancorp for $123M, Expanding Iowa Footprint
Equity Bancshares NYSE: EQBK has agreed to merge with Lincoln Bancorp, the parent company of Lincoln Savings Bank, in a transaction valued at approximately $123 million that would expand Equity's footprint in Iowa.
TBBK -0.27% 
Matrix Service Q4 Earnings Call Highlights
Matrix Service NASDAQ: MTRX reported improved fourth-quarter fiscal 2026 results, including higher revenue, stronger gross margins and a return to adjusted profitability, as the engineering and construction contractor advances a strategic plan aimed at improving project selection, execution and cost discipline.
MTRX -1.72% 
John Wiley & Sons Q1 Earnings Call Highlights
John Wiley & Sons NYSE: WLY said its first-quarter fiscal 2027 performance met its internal plan as growth in research publishing and artificial intelligence-related offerings was offset by a difficult comparison with the prior year and continued weakness in learning markets.
WLY -2.86% 
BASFY Strengthens Acid Chlorides and Chloroformates Production
BASF modernizes its Ludwigshafen ACCF plant, lifting capacity by about 30% and cutting the portfolio's carbon footprint by an average of 19%.
BASFY +1.07% 
ONON Falls 27.2% in a Month. Does the Sell-Off Create Opportunity?
ONON's 27.2% monthly slide has reset its valuation, but tariff risks, wholesale restraint and rising costs cloud the near-term opportunity.
ONON +2.15% 
QCOM's Japan Robotics Outlay Targets Edge AI: Reason to Buy the Stock?
Qualcomm's Japan robotics push targets edge AI growth and diversification, but margin pressure, weak estimates and Apple's modem shift cloud the outlook.
QCOM +1.53% 
AMC Enters Film Distribution With Leawood Films: Time to Buy the Stock?
AMC's Leawood Films adds a new growth avenue as record EBITDA and premium-format demand support momentum, but leverage and cash-flow risks remain.
AMC +0.36% 
Solaris Energy Expands Power Infrastructure With Omega Deal
SEI's $101M Omega deal adds specialized EPC expertise, expands its power infrastructure platform and targets growing data center demand.
SEI +4.97% 
Is ONON Worth Buying Now as Growth Collides With Execution Risks?
ONON's broad growth and stronger DTC mix support momentum, but rising costs, wholesale restraint and U.S. tariffs make the lower valuation a mixed entry point.
ONON +2.15% 
